StockData
Sinovac Biotech Ltd logo

Sinovac Biotech Ltd (SVA) stock

SVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 5, 2026Score 7/30
$6.47+0.00 (0.00%)

Close on Nov 17, 2026Market cap $464.94MP/E –Yield 850.08%

Sinovac Biotech price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Sinovac Biotech's price to sales ratio was 1.2× on Nov 11, 2026, against 1.3× a year earlier. Over the last 5 years it ranged from 0.0× to 1.3×, with a median of 1.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.2×−0.1
2025Dec 31, 20251.3×+0.3
2024Dec 31, 20241.0×+0.7
2023Dec 29, 20230.3×+0.3
2022Dec 30, 20220.0×−1.2
2021Dec 31, 20211.3×−1.3
2020Dec 31, 20202.6×+0.6
2019Dec 31, 20192.0×−0.3
2018Dec 31, 20182.3×−3.9
2017Dec 29, 20176.2×+1.2
2016Dec 30, 20165.0×−0.1
2015Dec 31, 20155.1×+1.0
2014Dec 31, 20144.0×−2.8
2013Dec 31, 20136.9×+3.8
2012Dec 31, 20123.0×−0.6
2011Dec 30, 20113.6×+1.3
2010Dec 31, 20102.3×–

More Sinovac Biotech figures

See a number that looks wrong?